Skip to main content

Find Clinical Trials

Home
Conditions
Movement Disorders

Clinical trial condition

Movement Disorders

Explore clinical trials studying Movement Disorders. Study availability and eligibility vary by location and protocol.

4,237 public trials 786 recruiting studies

Refine in advanced search Browse all conditions

Movement Disorders trial results

Completed

Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease

NCT00292227

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Farmovs-Parexel (Pty) Ltd Bloemfontein, South Africa

Qdot, a division of Parexel International DA (Pty) Ltd. George, South Africa

View Trial Details

Completed

Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls

NCT01348061

Conditions: Alzheimer Disease, Basal Ganglia Diseases, Brain Diseases, +18 more
Locations: Parexel Glendale, California, United States

Memory Enhancement Centers of America Inc. Eatontown, New Jersey, United States

Worldwide Clinical Trials San Antonio, Texas, United States

View Trial Details

Completed

Exercise Interventions in Parkinson's Disease

NCT01439022

Conditions: Basal Ganglia Diseases, Behavior, Brain Diseases, +13 more
Locations: Oxford Brookes University Oxford, Oxfordshire, United Kingdom

View Trial Details

Completed

A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease

NCT00139867

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Schwarz Milwaukee, Wisconsin, United States

View Trial Details

Completed

Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects

NCT01964573

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Seoul, South Korea

View Trial Details

Completed

A Follow-up Study on Safety and Tolerability of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease

NCT01807338

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Department of Neurology, Skåne University Hospital Lund, Sweden

View Trial Details

Completed

Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease

NCT00892450

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +19 more
Locations: VA Medical Center, Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine

NCT00593606

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Not specified

View Trial Details

Completed

Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of Parkinson Symptoms

NCT00296192

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Not specified

View Trial Details

Completed

An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's Disease

NCT00505687

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Birmingham, Alabama, United States

St. Petersburg, Florida, United States

Fort Wayne, Indiana, United States

Southfield, Michigan, United States

View all 26 locations

View Trial Details